Response to "The Self-Controlled Case Series Design as a Viable Alternative to Studying Clinically Relevant Drug Interactions"

Clin Pharmacol Ther. 2020 Feb;107(2):323. doi: 10.1002/cpt.1630. Epub 2019 Oct 21.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Comment

MeSH terms

  • Delivery of Health Care*
  • Drug Interactions
  • Humans
  • Research Design*